Allogene Therapeutics
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 233
- Market Cap
- $560.4M
- Website
- http://www.allogene.com
- Introduction
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells a...
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Allogene Therapeutics
- Target Recruit Count
- 250
- Registration Number
- NCT06500273
- Locations
- 🇺🇸
Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸University of Louisville Health Brown Cancer Center, Louisville, Kentucky, United States
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
- Conditions
- Interventions
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Allogene Therapeutics
- Target Recruit Count
- 70
- Registration Number
- NCT05714345
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussel, Belgium
🇺🇸University of Louisville James Graham Brown Cancer Center, Louisville, Kentucky, United States
Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2021-08-11
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Allogene Therapeutics
- Target Recruit Count
- 6
- Registration Number
- NCT05000450
- Locations
- 🇺🇸
St. David's South Austin Medical Center, Austin, Texas, United States
🇺🇸Sarah Cannon/Colorado Blood Cancer Institute, Denver, Colorado, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Allogene Therapeutics
- Target Recruit Count
- 120
- Registration Number
- NCT04696731
- Locations
- 🇺🇸
UCSF Medical Center, San Francisco, California, United States
🇺🇸Yale School of Medicine, New Haven, Connecticut, United States
🇺🇸Georgetown University Hospital, Washington, District of Columbia, United States
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Allogene Therapeutics
- Target Recruit Count
- 160
- Registration Number
- NCT04416984
- Locations
- 🇺🇸
Northside Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸Augusta University, Augusta, Georgia, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
- Conditions
- Interventions
- First Posted Date
- 2019-09-18
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Allogene Therapeutics
- Target Recruit Count
- 132
- Registration Number
- NCT04093596
- Locations
- 🇺🇸
Stanford Cancer Institute, Palo Alto, California, United States
🇺🇸Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Allogene Therapeutics
- Target Recruit Count
- 74
- Registration Number
- NCT03939026
- Locations
- 🇺🇸
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸St. Davids South Austin Medical Center, Austin, Texas, United States